News
Fed rate cuts are unlikely to lower borrowing costs for American homebuyers, according to one CIO. Mortgage rates and home ...
Mike Wilson, Morgan Stanley chief U.S. equity strategist, joins 'Power Lunch' to discuss what could be coming for equity ...
Nevada, Maryland, and North Carolina lead in year-over-year inventory growth, with Nevada experiencing a 52.9% increase, ...
This year’s iteration of Harper’s Bazaar’s annual Icons event includes a September issue starring Dua Lipa on the cover, a ...
The S&P 500 posted gains in May, June, and July, a rare occurrence that has historically preceded more upside in the next ...
America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight.
Oatly's turnaround plan targets profitability by 2025 due to its brand and cost controls. Click here to read an analysis of ...
6hon MSN
Why one analyst thinks Nvidia could double its market cap to $9 trillion by the end of the decade
Nvidia's annual revenue could hit $600 billion by 2030, Melius Research said. The firm's Ben Reitzes says that implies a ...
A company with a chatbot that often gets things wrong is somehow about to become the largest unicorn earth has ever seen.
11hon MSN
Exclusive: India market regulator reconsiders intraday limits for equity derivatives, sources say
A top panel of India's market regulator is meeting on Tuesday to consider placing stricter limits on positions in index ...
Eight of the 10 biggest stocks in the S&P 500 are technology stocks, and tech as a sector represents 40 per cent of the value of the index. Today on the show, Katie Martin and Rob Armstrong ask if ...
Justin Zelin, BTIG senior biotech analyst, joins 'The Exchange' to discuss GLP-1's and the share decline for Viking Therapeutics and why he's still bullish the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results